MyMD Pharmaceuticals, Inc. - ROE
MYMD
Price:
$1.81
Market Cap:
$5.70M
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is a...[Read more]
Industry
Biotechnology
IPO Date
2014-01-23
Stock Exchange
NASDAQ
Ticker
MYMD
PE Ratio
[-0.20]
ROE
[-65.21%]
Current Ratio
[3.71]
Dividend Yield
[0%]
Enterprise Value
[4.58M]
Dividend History
The ROE as of July 2026 (TTM) for MyMD Pharmaceuticals, Inc. (MYMD) is -65.21%
According to MyMD Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -65.21%. This represents a change of 227.84% compared to the average of -19.89% of the last 4 quarters.
MyMD Pharmaceuticals, Inc. (MYMD) Historical ROE (quarterly & annually)
How has MYMD ROE performed in the past?
The mean historical ROE of MyMD Pharmaceuticals, Inc. over the last ten years is -48.80%. The current -65.21% ROE has changed 33.64% with respect to the historical average. Over the past ten years (40 quarters), MYMD's ROE was at its highest in in the March 2026 quarter at -5.25%. The ROE was at its lowest in in the June 2024 quarter at -2502.18%.
Average
-48.80%
Median
-78.44%
Minimum
-158.69%
Maximum
180.48%
MyMD Pharmaceuticals, Inc. (MYMD) ROE by Quarter and Year
Discovering the peaks and valleys of MyMD Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 406.78%
Maximum Annual ROE = 180.48%
Minimum Annual Increase = -170.03%
Minimum Annual ROE = -158.69%
| Year | ROE | Change |
|---|---|---|
| 2025 | -53.45% | -66.32% |
| 2024 | -158.69% | 406.78% |
| 2023 | -31.31% | -69.72% |
| 2022 | -103.42% | -18.18% |
| 2021 | -126.40% | -170.03% |
MyMD Pharmaceuticals, Inc. (MYMD) Average ROE
How has MYMD ROE performed in the past?
The current ROE of MyMD Pharmaceuticals, Inc. (MYMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-81.15%
5-year avg
-94.66%
10-year avg
-48.80%
MyMD Pharmaceuticals, Inc. (MYMD) ROE vs. Peers
How is MYMD’s ROE compared to its peers?
MyMD Pharmaceuticals, Inc.’s ROE is less than Gamida Cell Ltd. (1.15%), greater than Aptose Biosciences Inc. (-23.18%), greater than Hillstream BioPharma, Inc. (-36.93%), greater than Nabriva Therapeutics plc (-201.91%), greater than VivoSim Labs, Inc. (-277.62%), greater than Altamira Therapeutics Ltd. (-111.64%), greater than Gritstone bio, Inc. (-124.41%), greater than Onconetix, Inc. (-105.46%), greater than Unity Biotechnology, Inc. (-148.97%), greater than Neuphoria Therapeutics Inc. (-113.35%),
| Company | ROE | Market cap |
|---|---|---|
| 1.15% | $4.34M | |
| -23.18% | $4.36M | |
| -36.93% | $4.17M | |
| -201.91% | $323.00 | |
| -277.62% | $1.08M | |
| -111.64% | $1.13M | |
| -124.41% | $3.80M | |
| -105.46% | $274.31K | |
| -148.97% | $3.44M | |
| -113.35% | $19.67M |
Build a custom stock screener for MyMD Pharmaceuticals, Inc. (MYMD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MyMD Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
MyMD Pharmaceuticals, Inc. (MYMD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like MyMD Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is MyMD Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the highest ROE for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the 3-year average ROE for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the 5-year average ROE for MyMD Pharmaceuticals, Inc. (MYMD)?
How does the current ROE for MyMD Pharmaceuticals, Inc. (MYMD) compare to its historical average?